红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性

余梅玫, 徐岩. 红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性[J]. 临床心血管病杂志, 2012, 28(7): 492-495. doi: 10.13201/j.issn.1001-1439.2012.07.009
引用本文: 余梅玫, 徐岩. 红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性[J]. 临床心血管病杂志, 2012, 28(7): 492-495. doi: 10.13201/j.issn.1001-1439.2012.07.009
YU Meimei, XU Yan. Relationship between total cholesterol content of erythrocyte membranes and acute coronary syndrome[J]. J Clin Cardiol, 2012, 28(7): 492-495. doi: 10.13201/j.issn.1001-1439.2012.07.009
Citation: YU Meimei, XU Yan. Relationship between total cholesterol content of erythrocyte membranes and acute coronary syndrome[J]. J Clin Cardiol, 2012, 28(7): 492-495. doi: 10.13201/j.issn.1001-1439.2012.07.009

红细胞膜总胆固醇含量与急性冠状动脉综合征的相关性

详细信息
    通讯作者: 余梅玫,E-mail:ahymm@yahoo.cn
  • 中图分类号: R541.4

Relationship between total cholesterol content of erythrocyte membranes and acute coronary syndrome

More Information
  • 目的:研究红细胞膜总胆固醇含量(CEM)与急性冠状动脉综合征(ACS)的相关性。方法:204例胸痛患者行冠状动脉造影后分成ACS组98例,稳定型心绞痛(SAP)组45例和对照组61例。采用酶学的方法测定各组CEM水平,用ELISA法测定血清高敏C反应蛋白(hs-CRP)水平。结果:ACS组CEM值为(149.50μg/mg,120.33~180.11μg/mg),较SAP组(79.98μg/mg,56.75~97.56μg/mg)及对照组(76.64μg/mg,62.12~91.84μg/mg)均明显增高(均P<0.05)。多因素逻辑回归分析提示CEM与ACS发病显著相关(OR 24.990,95%CI5.220~119.596,P<0.01)。CEM水平与血清hs-CRP呈显著正相关(r=0.328,P<0.01)。结论:CEM可能通过炎症反应参与ACS发病的进程,是动脉粥样易损斑块的一个潜在标记物,对于ACS的预测作用优于hs-CRP。
  • 加载中
  • [1]

    TZIAKAS D N,KASKI J C,CHALIKIAS G K,etal.Total cholesterol content of erythrocyte mem-branes is increased in patients with acute coronarysyndrome:a new marker of clinical instability?[J].JAm Coll Cardiol,2007,49:2081-2089.

    [2]

    KOLODGIE F D,BURKE A P,NAKAZAWA G,etal.Free cholesterol in atherosclerotic plaques:wheredoes it come from?[J].Current Opinion in Lipidolo-gy,2007,18:500-507.

    [3]

    ARROYO-ESPLIGUERO R,AVANZAS P,COSIN-SALES J,et al.C-reactive protein elevation and dis-ease activity in patients with coronary artery disease[J].Eur Heart J,2004,25:401-408.

    [4]

    BRONCEL M,CHOJNOWSKA-JEZIERSKA J,KOT-ER-MICHALAK M,et al.Erythrocyte fluidity in pa-tients with hyperlipidemia during statins therapy[J].PolArch Med Wewn,2005,113:531-537.

    [5]

    MIWA S,INOUYE M,OHMURA C,et al.Rela-tionship between carotid atherosclerosis and erythro-cyte membrane cholesterol oxidation products in type2diabetic patients[J].Diabetes Res Clin Pract,2003,61:81-88.

    [6]

    DE BACKER G,AMBROSIONI E,BORCH-JOHNS-EN K,et al.European guidelines on cardiovascular dis-ease prevention in clinical practice.third joint task forceof european and other societies on cardiovascular diseaseprevention in clinical practice[J].Eur Heart J,2003,24:1601-1610.

    [7]

    PASTERKAMP G, VIRMANI R. The erythrocyte:a new player in atheromatous core formation[J]. Heart,2002,88:115-116.

    [8]

    TABAS I. Cholesterol and phospholipid metabolism in macrophages[J]. Biochem Biophys Acta,2000,1529:164-174.

    [9]

    ARBUSTINI E.Total erythrocyte membrane choles-terol:an innocent new marker or an active player in a-cute coronary syndromes?[J].J Am Coll Cardiol,2007,49:2090-2092.

    [10]

    ARBUSTINI E,MORBINI P,D'ARMINI A M,etal.Plaque composition in plexogenic and thromboem-bolic pulmonary hypertension:the critical role of thethrombotic material in pultaceous core formation[J].Heart,2002,88:177-182.

    [11]

    KOLODGIE F D, GOLD H K, BURKE A P, et al. Intraplaque hemorrhage and progression of coronary atheroma[J]. N Engl J Med,2003,349:2316-2325.

    [12]

    LIN H L,XU X S,LU H X,et al.Pathologicalmechanisms of erythrocyte-induced vulnerability ofatherosclerotic plaques Med Hypotheses[J].Med Hy-potheses,2008,70:105-108.

  • 加载中
计量
  • 文章访问数:  66
  • PDF下载数:  19
  • 施引文献:  0
出版历程
收稿日期:  2011-11-20
修回日期:  2012-01-15

目录